| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |